A uroguanylin-GUCY2C endocrine axis regulates feeding in mice

Central and Peripheral Molecular Targets for Antiobesity Pharmacotherapy

(2010) M A Valentino et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Recent advances in understanding leptin signaling and leptin resistance

(2009) David L. Morris et al.   AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM

The Hormone Receptor GUCY2C Suppresses Intestinal Tumor Formation by Inhibiting AKT Signaling

(2009) Jieru Egeria Lin et al.   GASTROENTEROLOGY

Increased Lipid Absorption and Transport in the Small Intestine of Zucker Obese Rats

(2009) Keizo Anzai et al.   JOURNAL OF CLINICAL BIOCHEMISTRY AND NUTRITION

Differential susceptibility to obesity between male, female and ovariectomized female mice

(2009) Jina Hong et al.   Nutrition Journal

Insulin, cGMP, and TGF-β Signals Regulate Food Intake and Quiescence in C. elegans: A Model for Satiety

(2008) Young-jai You et al.   Cell Metabolism

Uroguanylin, an Intestinal Natriuretic Peptide, Is Delivered to the Kidney as an Unprocessed Propeptide

(2008) Nicholas G. Moss et al.   ENDOCRINOLOGY

Circulating Prouroguanylin Is Processed to Its Active Natriuretic Form Exclusively within the Renal Tubules

(2008) Xun Qian et al.   ENDOCRINOLOGY

Guanylyl Cyclase C–Induced Immunotherapeutic Responses Opposing Tumor Metastases Without Autoimmunity

(2008) Adam E. Snook et al.   JNCI-Journal of the National Cancer Institute

Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies

(2008) Andrew G Renehan et al.   LANCET

Effects of the gut microbiota on host adiposity are modulated by the short-chain fatty-acid binding G protein-coupled receptor, Gpr41

(2008) B. S. Samuel et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA